|
CN102439021A
|
|
Novel galactoside inhibitors of galectins
|
|
WO2010107380A1
|
|
Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis and related proteins, peptides and compositions
|
|
CN102341060A
|
|
Zirconium dioxide based prostheses
|
|
EP2305277A1
|
|
Use of tolerogenic dendritic cells in treatment and prevention of atherosclerosis
|
|
CN102105162A
|
|
The use of Wnt5-a peptide derivates for the treatment of melanoma and gastric cancer
|
|
WO2009142598A1
|
|
Mechanical barrier disc in wound healing
|
|
WO2009139719A1
|
|
Novel synthesis of galactoside inhibitors
|
|
CA2720464A1
|
|
Gabaa receptor modulators
|
|
WO2009123536A1
|
|
NEW CLASSES OF GABAa/BZR LIGANDS
|
|
WO2009099378A1
|
|
Selection of rna-aptamers as anti-malaria agents
|
|
EP2205103A1
|
|
Method and apparatus for making food chips
|
|
WO2009035402A1
|
|
Diagnosis of cancer by determining polymorphisms in blm, top3a or rmil
|
|
WO2008127193A1
|
|
Metalled sirnas for facilitated targeting of suboptimal mrna sequences
|
|
WO2008121046A1
|
|
Improvement of gastric emptying in patients suffering from diabetes mellitus
|
|
CA2670095A1
|
|
Gall midge pheromone mixture
|
|
WO2008063118A1
|
|
Improving release of insulin
|
|
ZA200705935B
|
|
Arabinose- and xylose-fermenting saccharomyces cerevisiae strains
|
|
WO2007136336A1
|
|
Diagnosis of increased risk of acute myocardial infarction
|
|
WO2008082343A1
|
|
Olive waste recovery
|
|
EP1937559A1
|
|
Replacement of heavy gaseous material
|
